FOXA1 and nasopharyngeal carcinoma: Moreover, our study demonstrated that FOXA1 silencing in NPC cells enhanced cisplatin resistance, as evidenced by increased proliferative capacity, migratory/invasive potential, and reduced cisplatin-induced apoptosis and cell cycle arrest.